BTX - 3.34 pre-market now at 3.44/3.47 BioTime Forms New Subsidiary AgeX Therapeutics, Inc. to Develop its Programs Focused on Human Aging http://stockcharts.com/c-sc/sc?s=BTX&p=D&b=5&g=0&i=t76652360109&r=1491480422313 http://stockcharts.com/c-sc/sc?s=BTX&p=W&b=5&g=0&i=t57494735624&r=1491480387169